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The emergence of the group B Streptococcus as a leading agent of neonatal sepsis and 
meningitis (1) has stimulated interest in furthering understanding of the biology and 
immunochemistry of this organism. Various antigens of the five major human group 
B streptococcal serotypes have been under recent investigation, including type-specific 
antigens  (2-4)  as  well  as  an  intracellular  enzyme,  hippuricase  (5),  and  also  the 
extracellular  enzyme, neuraminidase  (6),  and  CAMP protein  (7). Advances in  our 
knowledge of the group B Streptococcus have been the subject of recent reviews (8-10). 
Our studies  were undertaken  to explore the possibility that  group B  streptococci 
may elaborate extracellular  nucleases  different  from those of group A  streptococci, 
and  that  these  nucleases  may be  valuable antigenic markers  that  could be  used  to 
follow the immune response to group B streptococcal colonization or infection. 
The frequency of production of extracellular DNase had been reported to be 38% 
in  group  B  streptococci  in  contrast  to  100% in  group  A  streptococci  (11).  The 
possibility that these differences might be a result of the production of lower levels  of 
enzyme by group B streptococci led  to the examination  of methods  that  are  more 
sensitive for screening group B streptococcal strains  for nuclease activity. Because of 
the  high  prevalence  of nuclease  activity detected  in  the  initial  screening  of many 
group B streptococcal strains (vide infra), studies were continued to isolate the nucleases 
and to characterize them biochemically and immunologically. 
Materials and Methods 
Bacteria.  The group B streptococci were recent  human isolates from the maternal genital 
tract,  and from the  mucosal sites, blood, and cerebrospinal  fluid of infants.  Identification  of 
their  serological  group was  by the  hot-acid  extraction  and  capillary  precipitin  method of 
Lancefield  (12), and typing was done by immunodiffusion  in agar (13) and also by capillary 
precipitin  technique  using rabbit antisera  prepared  in our laboratory. (grouping) and antisera 
provided  by the Center for Disease Control,  Atlanta, Ga.  (typing). Streptococcal  strains  were 
grown up to log phase and frozen in small aliquots  at -20°C. 
Preparation of Extracellular Material.  Cultures  of group B streptococci  were grown in vol of 
10-30 ml for screening of nuclease activity in DNA-methyl green (MG) I agar and in vol up to 
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5-10 1 for preparative work.  Frozen log-phase cultures were transferred to Todd-Hewitt broth 
(Difco Laboratories, Detroit, Mich.) and incubated overnight at 37°C. All subsequent opera- 
tions were carried out at 4°C. The supernatant fluid was adjusted to 85% saturation with solid 
(NH4)2SO4 and stirred for 1 h. The precipitate was collected by centrifugation at  10,000 g for 
20 min then dissolved in 1/10 vol 0.001  M  Tris, pH  7, containing 0.001  M  CaC12, 0.001  M 
MgCIz, and 0.0001 M mercaptoethanol, and was dialyzed for 3 h against the same buffer with 
several changes of buffer. After dialysis, the crude preparations were concentrated to t/10 of the 
original vol in dialysis tubing (Fisher Scientific Co., Pittsburgh, Pa.) with Carbowax Polyethyl- 
ene Glycol 20M (Union Carbide Corp., Carbon Products Div., New York)  for 4-5 hours and 
then dialyzed against the same buffer. The material was then either fractionated or stored at 
-20°C. 
Screening  for Nuclease Activity in DNA-MG Agar Plates.  An adaptation of a previously described 
technique was used to screen for nuclease activity (14). Wells of 15-mm Diam were cut in agar 
plates containing 1.5% Noble agar  (Difco  Laboratories), 0.5  mg/ml of DNA  (calf thymus, 
Sigma Chemical Co., St. Louis, Mo.) and 0.13 mg/ml of MG dye (Fisher certified stain, Fisher 
Scientific Co.). As indicated below, 30-70/*1 of crude (concentrated but unfractionated) enzyme 
preparations or 30/*1 of eluates of polyacrylamide gel slices were placed in the wells. The plates 
were incubated at 37°C and readings taken at 2, 4, and 18-24 h. Enzyme activity was evaluated 
by  the  presence  of zones  of decolorization which  reflected  degradation  of the  DNA-MG 
complex. The control enzyme was  from a  lot of purified standard DNase  B  from  group A 
streptococci, prepared in our laboratory. 
Assays of DNase Activity.  Nuclease activity was assayed by measurement of the acid-soluble 
fraction as described previously by Marker and Gray (14) and also by the microtiter method 
with DNA-MG as substrate as described by Nelson et al. (15). 
Assay of RNase Activity.  RNA was prepared from baker's yeast which was pretreated with 
pancreatic DNase I to remove contaminating  DNA. The assay mixture contained 0.01 M Tris- 
HCI, pH 7, 0.001 M CaC12, 0.001 M MgCI2, and 0.5 mg RNA in a total vol of 1.0 ml including 
the enzyme solution. After incubation at  37°C, the samples were processed  as  for  the acid- 
soluble assay of DNase activity (14). 
Protein Assay.  Protein was measured by absorbance at 280 nm or by the method of Lowry 
et al. (16). 
DEAE-Cellulose Chromatography.  The crude ammonium sulfate precipitates of extracellular 
products were  applied to  DEAE-cellulose (Whatman DE-23,  H.  Reeve Angel & Co.,  Inc., 
Clifton, N. J.) columns (2.5 x  30 cm) previously equilibrated with 0.001  M  Tris-HCl, pH 7, 
containing 0.001  M  CaC12, 0.001  M  MgC12, and 0.001  M  dithiothreitol (TCMD buffer) and 
eluted with a linear gradient of 0-0.25 M NaCI in the equilibrating  buffer. All chromatographic 
separations were  done  at  4°C.  Protein  elution was  monitored by  absorbance at  280  nm. 
Nuclease  activity was  assayed  by  the  acid-soluble technique.  Pooled  fractions of nuclease 
activity were concentrated by the Carbowax method and then dialyzed against TCMD buffer. 
Carboxymethyl Cellulose Chromatography.  Nuclease fractions from DEAE chromatography were 
applied to carboxymethyl (CM)-cellulose (Whatman CM-52, H. Reeve ~kngel and Co., Inc~) 
columns previously equilibrated with TCMD buffer. The columns were eluted with a  linear 
gradient of 0-0.25 M NaC1 in TCMD. 
Polyacrylamide Gel Electrophoresis,  Electrophoresis in 7.5% polyacrylamide gels was carried out 
using the  method of Davis  (17) as adapted  by Marker and Gray  (14). For some screening 
experiments, concentrated and dialyzed ammonium sulfate precipitates of extracellular prod- 
ucts were  subjected directly to electrophoresis in  7.5% polyacrylamide gels.  Gel slices were 
eluted overnight with TCMD buffer, and the gel eluates were assayed for nuclease activity by 
diffusion in DNA-MG agar and by the acid-soluble method. 
Molecular Weights.  Molecular weights of the  nucleases were examined by the method of 
Hedrick and Smith (18) using nondenaturing polyacrylamide gel electrophoresis. A series of 
marker  proteins  was  used  for  calibrations. These  were  pepsin,  myoglobin, bovine serum 
albumin, lactate dehydrogenase, and ovalbumin. Active fractions of nucleases from  DEAE 
columns were run with the standards in 4-10% polyacrylamide gels. The values were calculated 
as the average from six separate experiments. 
In addition, molecular weights were  determined by gel  filtration using Sephadex  G-100 
(Pharmacia  Fine Chemicals,  Div.  of Pharmacia,  Inc.,  Piscataway,  N.  J.)  in  2.5-  x  45-cm 58  GROUP  B  STREPTOCOCCAL NUCLEASES 
columns equilibrated with TCMD  buffer containing 0.2  M  NaCl by the method of Andrews 
(19).  The protein standards  were bovine serum albumin, ovalbumin, bovine hemoglobin, and 
myoglobin. Molecular weights of the nucleases were averages of at  least two determinations. 
Heat Stability and pH Optima of Nucleases.  Samples of the nucleases from DEAE chromatog- 
raphy  were incubated  separately  for 30 min at  37,  56,  65, and  80°C.  Activity of heated  and 
unheated  samples was determined by the microtiter plate method (15). 
The relative rates of reaction of the group B nucleases were studied after adjustment  of the 
pH of the assay mixture in increments from pH 6 to 9 in 0.001  M  Tris buffer, at pH 6 in 0.001 
M  KH2PO4 buffer, and at pH 9 and  pH  10 in 0.001  M  glycine buffer.  Nuclease activity was 
measured by the acid-soluble method. 
Cationic Requirements.  The  DNA was  dialyzed  against  0.05  M  EDTA,  pH  7,  then  against 
0.01  M  Tris  buffer,  pH  7,  to  remove any  traces  of divalent  cations.  In  the  absence  of any 
divalent  cations,  DNase  activity  was  negligible.  The  single  divalent  cations  studied  were 
calcium, magnesium, and manganese in final concentration of i0  -1- I0 -~ M. Combinations of 
calcium and magnesium, calcium and manganese, and magnesium plus manganese were also 
examined with the same range of final molarities.  Enzyme activity was measured by the acid- 
soluble method. 
Animal  Immunizations and Production of Antisera.  Initially,  as  part  of another  study  in  this 
laboratory, guinea pigs (males of 600-900 g) were injected with whole, heat-killed broth cultures 
of group B streptococci s.c.  (0.3  ml of an  18-h culture containing  10  s colony-forming units/ml 
and heated at 56°C for 1 h) for two to six injection series. Each series consisted of twice-weekly 
injections for 2-4 wk with a rest period of 2-21/2 wk between each series. Blood was obtained by 
cardiac puncture from ether-anesthetized animals before beginning injections and at ~4- to 5- 
wk  intervals.  In  many  experiments,  animals  were  later  boosted  with  a  crude  extracellular 
preparation  containing  nuclease  activity  from  the  strain  used  for  initial  immunizations. 
Typically, a 0.1- to 0.25-ml vol was injected s.c.  twice weekly for 2 wk, the animals were rested 
for 2-4 wk and a second and/or third booster series was given. Bleedings were taken 3-7 d after 
each booster series. Groups of 10-20 animals were used for each experiment. 
When  individual  nucleases  became  available  from  DEAE-cellulose fractionation,  animals 
were  boosted  with  these  enzymatically  active preparations.  In  addition,  some  animals  were 
given primary immunizations with crude extracellular nuclease preparations. 
Adult  New  Zealand  rabbits  weighing 2.5  kg,  in  groups  of  10,  were also  immunized  with 
heat-killed broth  cultures  and  boosted  with  crude extracellular material  exhibiting  nuclease 
activity and/or with active peaks  from DEAE chromatography.  1 ml of bacteria was injected 
and the vol of crude or partially purified enzyme given was 0.3 ml. Schedules of immunization 
and bleedings were similar to that  described for the guinea pigs. Blood was obtained from ear 
veins. 
Initial experiments involved immunization of 19 guinea pigs with strain No. 50 (nontypable) 
that  was later found to elaborate predominantly nuclease I  and small amounts of nuclease II. 
In  later  immunization  experiments,  an  attempt  was  made  to choose strains  that  elaborated 
only  one  nuclease  as  documented  by  ion-exchange  chromatography.  By  this  means,  it  was 
possible to obtain antisera  against  nuclease  I  and  nuclease III by immunization  with strains 
No,  16  and  No.  17,  respectively, and  their  homologous  nucleases.  No group  B  streptococcal 
strain was found to produce only nuclease II. Therefore, animals were immunized with strain 
No.  55,  that  produced  nucleases  I  and  II;  these  animals  were  boosted  with  a  DEAE  peak 
characteristic of nuclease II. 
Specific rabbit antisera to purified group A streptococcal nucleases, A, B, C, and D  and the 
purified group A streptococcal nucleases were available in our laboratory for comparisons with 
the group B streptococcal nucleases. 
Assays  of Antibody in  Animal  and  Human  Sera.  Neutralizing  antibodies  for  the  group  B 
streptococcal nucleases were assayed by an adaptation of the microtiter technique as described 
by Nelson et  al.  (15).  Sera were diluted  one to five and  inactivated  at  63°C.  Twofold serial 
dilutions  were  made  instead  of  the  usual  log  dilutions.  Neutralizing  antibody  titers  were 
expressed as the reciprocal of the serum dilution, and  10 was the lowest titer expressed. Slightly 
positive antibody titers meant that partial neutralization of the test enzyme was seen at a  final 
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Human  sera  were  obtained  from pregnant  women  in  labor,  and  infant  cord  sera were 
obtained  from placental  vessels. These patients were enrolled  in  epidemiological studies  of 
group  B  streptococcal  colonization,  and  written  permission  was  obtained  to  enlist  their 
participation in the studies.  Control sera were from hospitalized and nonhospitalized patients 
representing various illnesses and age groups. 
Results 
Screening Group B Streptococcal Strains for Nuclease Activity  in DNA-MG Agar Plates.  In 
preliminary experiments, crude extracellular products of the supernates of growth of 
64  group  B  streptococcal  strains  were  assayed  for  nuclease  activity.  After  a  2-h 
incubation  at  37°C,  zones  of decolorization  around  the  wells  containing  30  /11  of 
material indicated hydrolysis of DNA. 86% of the strains exhibited definite nuclease 
activity  using  this  agar  diffusion  method  (Table  I).  There  were  no  significant 
differences  in  frequency  of production  of enzyme  among  the  different  serotypes. 
Subsequently,  75  additional  group B streptococcal strains were tested, and  74 of 75 
(99%)  exhibited  enzymatic  activity when  60-70  #1  were  placed  in  the  wells.  This 
technique  was  more  sensitive  in  detecting  enzymatic  activity  than  the  microtiter 
method  (15)  or spectrophotometric  measurement of acid-soluble DNA degradation 
products (14). 
Isolation and Purification of Group B Streptococcal Nucleases.  The extracellular products 
of group B streptococcal strains exhibited one to three peaks of DNase activity when 
fractionated on DEAE-cellulose. There were three nuclease peaks, eluted from DEAE- 
cellulose, from strain No. 57, serotype III (Fig.  1). The enzymes have been designated 
as group B streptococcal nucleases I, II, and III according to the order of their elution 
from  DEAE  columns.  In  this  case,  the  earliest  eluted  peak contained  the  greatest 
activity. 
DEAE chromatography was carried out on the extracellular products of 10 group 
B streptococcal strains. The commonest pattern was detection of two nuclease peaks 
which corresponded to the earlier eluting two nuclease peaks (I and II) seen in Fig.  1. 
One strain  (No.  16)  was found to produce only nuclease I, one strain  (No.  17)  was 
found to produce only nuclease III, and the other seven strains produced nucleases I 
and II. 
The peaks from DEAE chromatography, representing good activity of nucleases I, 
II, and III from three different group B streptococcal strains were chromatographed 
separately on CM-cellulose at pH 7 (Fig. 2). This procedure added confirmation that 
the nucleases were three distinct species. As expected, the elution order was the reverse 
of the pattern seen with elution of nucleases I and III from DEAE-cellulose. The bulk 
of protein was separated from nucleases I and II during fractionation (Fig. 2 C  and B, 
respectively). 
Electrophoresis in  7.5%  polyacrylamide gels of the three different  nucleases from 
DEAE-cellulose revealed mobilities that were separate and distinct and confirmed the 
ion-exchange chromatographic findings  (Fig.  3). The relative mobility of nuclease I 
was the lowest with progressively greater mobilities for nucleases II and III. 
Molecular  Weights  of the Nucleases.  The  molecular weights  of the  three  nucleases 
were  determined  by  two  methods.  Migration  in  polyacrylamide  gels  of  varying 
concentration gave the following mol wt with their SD: nuclease I:  18,600  (+ 2,800); 
nuclease  II:  33,000  (± 8,800);  and  nuclease  III: 26,500  (± 6,700).  Using Sephadex  . 60  GROUP  B  STREPTOCOCCAL NUCLEASES 
TABLE  I 
Frequency of Nuclease Production by Group B Streptococcal Serotypes: Detection by Well-Diffusion in 
DNA-MG Plates 
Serotype  Number of strains tested  Number with nuclease activity 
Ia  11  9 
Ib  5  5 
Ic  29  28 
II  6  4 
III  11  8 
Nontypable  2  1 
Total  64  55 (86%) 
30/~1 of the  10-fold-concentrated extracellular preparation were placed in the  15-mm Diam wells cut in the 
agar plates and incubated at 37°C. 
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gel filtration  the mol wt  were:  nuclease  I:  18,500;  nuclease  II:  43,000;  and  nuclease 
III: 32,500. 
Cationic Requirements of Group B Streptococcal Nucleases.  In the absence of any divalent 
cations,  DNase  activity of the  three  nucleases  was  negligible.  For all  three  nucleases 
calcium  plus manganese  had  the greatest  activating effect. Manganese  was  the most 
effective of the single divalent cations (Table II). Other effective cationic combinations 
were  magnesium  and  manganese  for  nuclease  I  and  calcium  and  magnesium  for 
nucleases II and III. In all cases, 0.01-M concentrations of the cations exerted optimal 61 
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FIG.  2.  CM-cellulose chromatograms of nuclease peaks from DEAE-cellulose column eluates. C), 
nuclease activity  (Aze,0); O, protein  absorbance at  280 nm.  (A)  Nuclease III;  (B)  nuclease II;  (C) 
nuclease I. Incubation time for the acid-soluble assay was 30 min in (A)  and (B),  10 min in (C). 
activating effects. Studies employing divalent cations of cobalt, zinc, copper, mercury, 
and iron revealed no significant activation of nuclease III. 
Other Properties of the  Group B  Streptococcal Nucleases.  All  three  nucleases  actively 
degraded RNA but the rate of digestion was far less than for hydrolysis of DNA. The 
pH optima for all of the nucleases were quite broad with highest activity at pH 6 in 62 
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FIG.  3.  Polyacrylamide gel electrophoresis of nuclease peaks from DEAE-cellulose chromatogra- 
phy.  Nuclease activity was  measured  in  eluates of gel slices by the acid-soluble method. A260  nm 
nuclease I (O); nuclease II (9)); nuclease III (/X). 
TABLE  II 
Cationic Activation of Group B Streptococcal Nucleases 
Nuclease 
Relative nuclease activity 
Ca  +'~  Mg  ++  Mn ÷÷  Ca  ++ +  Ca  ++ +  Mg  +÷ + 
Mg  ++  Mn ++  Mn  ++ 
I  0.27  0.61  0.84  0.70  1  0.97 
II  0.55  0.41  0.80  0.99  1  0.78 
III  0.28  0.44  0.60  0.72  1  0.66 
The divalent cations, singly or in combination, were present in final concentration of 0.01  M. Maximum 
nuclease activity was seen with the combination of Ca  ++ plus Mn ++, and it was assigned a value of I; other 
values represent fractions of this activity. 
KHzPO4  buffer and  at pH  7-9 in Tris buffer. There  was less activity at pH  9  and  low 
activity  at  pH  10 in glycine buffer. 
Nucleases  I  and  III were relatively  heat stable  with  a  twofold  loss in activity  at  56, 
65, and  80°C  compared  to  a  control  incubated  at  37°C.  In contrast,  nuclease  II  had 
a  fourfold  to eightfold  reduction  in activity with  heating  at  65  and  80°C. 
The Immunogenicity of the Nucleases in Animals.  A  representative  example  ofa  humoral 
immune  response  to  nuclease-producing  group  B  streptococci  was  seen  in  19  guinea 
pigs injected  with  a  heat-killed  broth  culture  of strain  No.  50.  This  strain  elaborated PATRICIA FERRIERI, ERNEST GRAY, AND  LEWIS WANNAMAKER  63 
TABLE III 
Neutralizing Titers of Sera from Animals Injected with Strain No. 50for Nucleases Produced by Various 
Group B Streptococcal Strains 
Neutralizing titer for designated nuclease(s) of indicated strains 
Animal  No.  t6,  No.  17, 
number and  No.  50, nu-  No.  55, nu-  No.  7, nuclease  No. 57, nu- 
nu-  clease  clease  nu-  source of se-  clease  elease  clease 
rum 
1  II  I  I  II  I  II  I  II  IIl 
480  10  0  20  10  0  20  0  20  0  0 
483  10  0  10  10  0  10  0  10  0  0 
486  40  0  40  80  0  80  0  80  0  0 
488  10  0  20  20  0  20  0  20  0  0 
489  40  0  40  40  0  80  0  40  0  0 
492  20  0  40  40  0  40  0  40  0  0 
495  20  0  40  20  0  40  0  20  0  0 
primarily one nuclease, of the type designated I, but also produced smaller amounts 
of nuclease  II.  12  of the  19  injected  animals  developed  neutralizing  titers  of 10-40 
against  nuclease  I  by  2-4  mo  after  the  beginning  of the  series  of injections.  Five 
uninoculated controls were seronegative. The neutralizing capacity of the post-injec- 
tion  sera  of  7  of  these  12  animals  for  the  separate  nucleases  produced  by  the 
immunizing  strain  as  well  as  for the  nucleases  of five other  group  B  streptococcal 
strains  is  summarized  in  Table  III.  In  this  experiment,  the  hyperimmune  sera 
neutralized  nuclease I produced by the immunizing strain and neutralized  in similar 
titers,  nucleases I  produced by strains  No.  16,  No.  55, No.  7, and No.  57.  However, 
there was no neutralization  of nucleases II and III. 
In other experiments in which guinea pigs and rabbits were immunized with strain 
No.  16 which produced only nuclease I and boosted with crude enzyme, some animals 
developed  neutralizing  titers  to nuclease  I  produced  by the  various strains  listed  in 
Table III. 
Other  animal  injection  experiments  in  guinea  pigs  and  rabbits  revealed  that 
injection of a  strain  (No.  17)  that produced only nuclease III followed by boosters of 
partially purified nuclease III, resulted in hyperimmune sera that neutralized nuclease 
III as  well  as  nuclease  II  produced  by  a  number  of different  strains.  Conversely, 
injection of animals with a strain  (No. 55) that produced nucleases I and II, followed 
by  boosters  with  partially  purified  nuclease  II,  resulted  in  antisera  which  fully 
neutralized nuclease II as well as nuclease III; some antisera had partial neutralization 
of nuclease I  in low titer. 
Clearly, nuclease I was antigenically different  from nucleases II and III; nucleases 
II and  III appeared  antigenically  similar.  All three  nucleases were immunogenic in 
the experimental  animals. 
Immunological Comparison of Nucleases of Group B and Group A  Streptococci.  Of special 
interest  was whether the group B nucleases were immunologically different from the 
nucleases of group A streptococci. None of the examples of the three group B nucleases 
was neutralized  by rabbit  antisera  specific for nucleases A, B, C, and D  of group A 
streptococci.  In  addition,  guinea  pig  and  rabbit  antisera  with  neutralizing  activity 64  GROUP B STREPTOCOCCAL NUCLEASES 
against  the nucleases of group B strains did not neutralize any of the four nucleases 
produced by group A streptococci. 
Screening and Prevalence of Spec~c Nucleases Among Group B Streptococcal Strains.  In an 
attempt  to screen  for the specific types of nucleases produced by  18 other group B 
streptococcal  strains,  (demonstrated  by  diffusion  in  DNA-MG  agar  to  elaborate 
DNase) the crude, concentrated extracellular products prepared by ammonium sulfate 
precipitation were  applied  directly to polyacrylamide gels.  The peaks of activity in 
the gel eluates were pooled and saved for immunological identification with antisera 
specific for the group B streptococcal nucleases. Using this screening method, 5 of the 
18 strains revealed two peaks of nuclease activity, and the others had only one obvious 
peak of activity in  the  gel  eluates.  There  was no pattern  of nuclease production in 
relation to specific serotype. The peaks from three of the five strains found to possess 
two nucleases were tested and identified tentatively as nuclease I and nuclease II/III 
by neutralization tests.  The single nuclease peaks from 5 of the other  13 strains were 
tested  immunologically and  were  unequivocally nuclease  II/III. Because small  vol- 
umes of culture supernates were processed in  this screening method, less amounts of 
nucleases were produced, and this may have decreased the chance of detecting all of 
the nucleases produced by a strain. In contrast, with DEAE fractionation of extracel- 
lular products of larger volumes of bacterial growth (vide supra),  7 of 10 other strains 
produced nucleases I  and  II, and one produced nucleases  I, II, and  Ill. This  direct 
screening method on polyacrylamide gels requires further study. 
Detection of Anti-Nuclease  Activity  in Mothers  and Infants  Harboring  Group B  Streptococcz 
versus Controls.  Studies were carried out to examine maternal/infant  immunological 
responses  to  the  group  B  nucleases.  Inclusion  in  the  test  group  required  that  the 
pregnant women had positive genital  tract  cultures  for group B streptococci during 
the  third  trimester  of pregnancy or at  time  of labor or that  their  newborn  infants, 
cultured immediately after delivery, had mucosal surface cultures positive for group 
B streptococci. 21 control mothers and their 21 infants were not colonized with group 
B  streptococci  at  any  of the  above  designated  times.  61  other  hospitalized  and 
nonhospitalized patients with various illnesses  were also studied. 
In  216  birthing  events  that  fulfilled  the  criteria  for  the  test  group,  13%  of the 
maternal  and/or infant  sera exhibited  definite neutralizing titers  of 1:10  or greater 
against  the  nucleases,  (Table  IV).  Commonly, titers  of 1:20 to  1:40  were seen,  and 
maternal/infant sera (when both were available) were concordant within one twofold 
dilution.  An additional  12%  exhibited  partial  activity (incomplete neutralization  at 
a  serum  dilution  of  1:10).  Among the  culture-negative  control  mother  and  infant 
pairs,  5% had definite neutralizing titers and  14% had partial  activity. In the group 
of 61 nonpregnant controls, 5% had definite and 5% had partial neutralizing activity. 
This latter group had various antibody titers for the group A streptococcal nuclease, 
DNase B, that did not correlate with the group B anti-nuclease activity. 
Analysis for a  possible  correlation  between  neutralizing  activity and  the  culture 
status  before  delivery  (third  trimester  and  labor)  revealed  an  equal  prevalence  of 
positive cultures in  both the third  trimester and at  time of labor in  the seropositive 
mothers and  infants  (52% with  positive cultures)  and  the seronegative mothers and 
infants  (59%  with  positive cultures).  There  was  no  difference  in  the  prevalence  of 
anti-nuclease activity in those women who were culture positive at both times (third 
trimester and labor) compared to those women with culture conversion (either positive 
to negative or the reverse)  between the third trimester and the time of labor. PATRICIA FERRIERI, ERNEST GRAY, AND  LEWIS WANNAMAKER  65 
TABLE IV 
Prevalence of Neutrah'zing Activity  to Group B Streptococcal Nucleases H  and III in the Sera of Mothers 
and Infants  and Controls" 
Patient group  Number 
Percentage with 
neutralizing activ- 
ity 
Definite  Partial 
Group B streptococcal-colonized mothers/infants 
Culture-negative mothers/infants 
Hospitalized/clinic patients 
% 
216 pairs  13  12 
21 pairs  5  14 
61  5  5 
It  is  curious  that,  with  two  exceptions,  all  of the  sera with  anti-nuclease  activity 
have neutralized,  in similar titer,  nucleases  II and III but  not nuclease I. Two adult 
patients,  one  with  group  B  streptococcal  meningitis  and  the  other  with  peritonitis, 
also had neutralizing titers for nucleases II and III. 
Discussion 
The extracellular  nucleases of group A  streptococci are produced by essentially all 
strains  (11). There are at least four distinct and purified nucleases designated A, B, C, 
and  D  that  have  been  studied  in  detail  for  their  biochemical  and  immunological 
properties  (20).  These  nucleases  are  endonucleolytic  in  their  action  on  DNA  (90). 
DNase B is of particular  interest  because of the high frequency of antibody responses 
to this  antigen  in the serum of patients  with  group A  streptococcal  infections of the 
throat  and  skin  as well  as in patients  with  post-streptococcal  sequelae  of rheumatic 
fever and acute glomerulonephritis  (21). 
20 yr ago, using crude whole supernates  and alcohol precipitation  of DNA, it was 
found  that  38%  of group  B  streptococcal  strains  elaborated  extracellular  nuclease 
activity  (11).  Until  our  recent  studies  were  carried  out  (22),  no  other  significant 
information had been available on the frequency of production of nucleases by group 
B streptococci, or on their biochemical and immunological characteristics.  Using the 
agar-well-diffusion  techniques  in  DNA-MG  agar  plates  for  screening  extracellular 
material,  it  was  found that  86%  of group B  streptococcal strains  exhibited  nuclease 
activity.  When  larger  volumes  of  material  were  placed  in  the  wells,  this  figure 
increased  to  nearly  100%.  However,  the  amounts  of DNase  produced  by  group  B 
streptococcal strains were generally significantly less than  the amounts  produced by 
group A  strains. 
Ion-exchange chromatography of the products of one group B streptococcal strain 
initially  revealed  only  one  peak  of  nuclease  activity.  When  many  strains  were 
examined,  it  was clear  that  most  strains  produced  two nucleases  and  one produced 
three  nucleases.  Elution  patterns  of these  nucleases  from both  DEAE-cellulose  and 
CM-cellulose columns revealed that  three different  nucleases had been isolated,  and 
their  migration  patterns  in  7.5%  polyacrylamide gels  also substantiated  their  desig- 
nation  as  separate  species  of nucleases.  Although  these  nucleases  have  not  been 
purified  to  homogeneity,  preliminary  determinations  of  molecular  weights  were 
carried  out.  The  relative  molecular  weights  of the  nucleases,  determined  by  two 
independent  methods, were:  I <  III <  II. 66  GROUP B STREPTOCOCCAL NUCLEASES 
All  three  group  B  streptococcal nucleases  were  maximally activated  by divalent 
cations of calcium plus manganese. This is similar to the four nucleases of group A 
streptococci which  exhibit  optimum  activity  in  the  presence  of these  two divalent 
cations. 2 
Of considerable  interest  was  whether  the  group  B  streptococcal  nucleases  were 
immunogenic.  Extensive  immunization  experiments  in  animals  revealed  that  after 
injection of heat-killed,  whole broth cultures of bacteria,  neutralizing activity to all 
three nucleases could be provoked, and also that partially purified nucleases boosted 
the response.  The immunologic role of the bacterial  ceils  is  not clear,  but  the cells 
could have served as a direct source of nuclease or have functioned as an adjuvant for 
the nuclease antigen. In many cross-neutralization studies it was found that antisera 
that neutralized nuclease I did not neutralize nucleases II and III. Curiously, antisera 
to nucleases II and III cross-neutralized these two nucleases in equal titer, suggesting 
that they may share a common antigenic determinant, despite their distinction on the 
basis of several other properties detailed here. 
In pursuing  further  the  immunological identity of the  group B  nucleases  it  was 
found that they were not neutralized at all by specific antisera for the four group A 
streptococcal  nucleases,  and  that  guinea  pig  and  rabbit  antisera  for  the  group  B 
nucleases  did  not  neutralize  the  purified  group  A  nucleases.  This  immunological 
difference between  the nucleases of these two serological groups of streptococci was 
intriguing  and  fortunate.  A  biological  antigenic  marker,  such  as  the  extracellular 
nucleases  with  their  immunological  uniqueness,  can  be  useful  in  confirming  the 
specificity of a  serological  response  for either  a  group  A  or  group  B  streptococcal 
infection. 
An extension  of this  immunological probing was to examine  sera  from pregnant 
women harboring group B streptococci and from their newborn infants for neutral- 
izing activity to  the  group  B  streptococcal nucleases.  In 25%  of 216  mother-infant 
pairs fitting the bacteriologic criteria for study, one or both of them were seropositive, 
divided equally between definite neutralizing titers and titers of partial neutralization. 
In contrast, a small group of  culture-negative mothers and infants had a 5% prevalence 
of definite titers and a  14% prevalence of slight neutralizing activity in their serum. 
Thus, it appeared that recent colonization with group B streptococci may lead to an 
immune response to the group B streptococcal nucleases. The generally equal titers in 
paired maternal and cord sera suggest that antibodies to these nucleases readily cross 
the placenta.  Studying the chronology of development of neutralizing activity with 
several bleedings will be a  natural extension of these preliminary findings.  Demon- 
stration of neutralizing activity in culture-negative controls may be a result of previous 
colonization with group B streptococci in a  population known to commonly harbor 
these  bacteria  (23).  The seropositivity in  the  other heterogeneous controls  (culture 
status  unknown)  was  unexplained  but  may reflect  common exposures  to  group  B 
streptococci. 
Although all three nucleases were immunogenic in animals, human sera, with rare 
exceptions, neutralized equally well only nucleases II and III. Perhaps nuclease I is a 
poor immunogen in humans, or is not produced in large amounts by the strains  to 
2  Gray, E. D., A. E. Flores, and S. C. Marker. Streptococcal  nuclease B: purification and characterization. 
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which humans are ordinarily exposed. This point requires  further investigation.  The 
neutralizing activity for the nucleases of group B  streptococci probably reflects  true 
antibody, although definitive proof for this is not available at this time. 
Summary 
Nearly all group B streptococcal strains representing the five major serotypes were 
found  to  produce  extracellular  nucleases  by  screening  with  an  agar-well-diffusion 
technique  in  DNA-methyl  green  agar  plates.  Three  different  nucleases  have  been 
isolated and partially purified by DEAE- and carboxymethyl-cellulose chromatogra- 
phy.  They possessed  different  mobilities  on  polyacrylamide gel electrophoresis  and 
different molecular weights.  These nucleases,  designated I, II, and III, are optimally 
activated by cations of calcium and manganese and exhibited RNase as well as DNase 
activity. Despite differences in their physical and biochemical properties, nucleases II 
and  III appear  antigenically  similar,  but  distinct  from  nuclease  I.  These  group  B 
streptococcal nucleases are immunologically different  from the nucleases of group A 
streptococci.  Neutralizing  activity,  probably  antibody,  to  nucleases  II and  III was 
found in human sera, and was most prevalent  in sera of pregnant women colonized 
with group B streptococci and in their newborn infants. 
The authors are grateful for the expert technical assistance of JoAnn Nelson and Thomas F. 
Slechta. 
Received for publication 4 September 1979. 
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